Colossal Secures $60M Series A Funding To Advance Genetic Engineering and De-extinction Technologies
DALLAS--(BUSINESS WIRE)--Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One Ventures ...
Future research aims to enhance TALEN's efficiency and specificity, potentially combining it with CRISPR or base editing technologies for advanced genetic engineering applications. Despite its ...
Over millennia, there has been a seamless continuum of technologies for genetic modification of plants, animals, and microorganisms, with progressive improvements in precision and predictability – a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results